HealthcareServices

Genetic Testing Services Market Outlook: Growth and Forecast Highlights 2030

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the genetic testing services market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Genetic Testing Services Market show for the 2026–2030 period?

The genetic testing services market size has experienced rapid growth in recent years. It is projected to expand from $21.36 billion in 2025 to $23.75 billion in 2026, with a compound annual growth rate (CAGR) of 11.2%. This historical growth can be attributed to factors such as consumer interest in ancestry testing, the availability of sequencing technologies, early adoption in academic research, growing awareness of inherited diseases, and laboratory service expansion.

The genetic testing services market size is anticipated to undergo substantial expansion in the coming years. By 2030, it is projected to reach $34.09 billion, growing at a compound annual growth rate (CAGR) of 9.5%. This growth during the forecast period is attributable to the integration of genomics into standard healthcare practices, the increasing desire for personalized health insights, the expansion of digital health platforms, enhanced regulatory clarity for testing services, and the advancement of preventive medicine. Significant trends expected in this period include the development of direct-to-consumer genetic testing services, a greater need for disease risk assessment services, the broadening of prenatal and newborn genetic services, the increasing acceptance of ancestry and genealogy testing, and a rise in the utilization of genetic counseling services.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15385&type=smp

What Drivers Are Shaping The Development Of The Genetic Testing Services Market?

The genetic testing services market is anticipated to expand due to the growing occurrence of genetic disorders. These disorders stem from abnormalities in an individual’s DNA, resulting in various physical or developmental issues. Factors contributing to their rising prevalence include greater awareness, enhanced diagnostic techniques, broader genetic screening programs, and an uptick in consanguineous marriages within certain demographics. Such services are increasingly crucial for diagnosing, predicting outcomes (prognosis), and guiding treatment choices for affected individuals, thereby facilitating personalized medical care and informed family planning strategies based on one’s unique genetic composition. For example, the World Health Organization (WHO) reported in February 2023 that congenital diseases led to an estimated 240,000 baby deaths worldwide annually within 28 days of birth. Additionally, data from the Centers for Disease Control and Prevention indicates that approximately 6,000 babies are born with Down syndrome in the United States every year, equating to about 1 in every 700 babies. Consequently, the expanding incidence of genetic disorders serves as a key driver for the genetic testing services market.

What Segment Types Are Examined In The Genetic Testing Services Market?

The genetic testing services market covered in this report is segmented –

1) By Type: Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Other Types

2) By Disease: Cancer Disease, Metabolic Disease, Cardiovascular Disease, Other Diseases

3) By End User: Diagnostic Laboratories, Hospitals And Clinics, Academic Institutes And Research Centers, Other End Users

Subsegments:

1) By Predictive Testing: Cancer Predisposition Testing, Heart Disease Risk Testing, Neurological Disorder Risk Testing, Other Predictive Tests

2) By Carrier Testing: Carrier Screening For Single-Gene Disorders, Carrier Screening For Multifactorial Conditions, Carrier Screening For Inherited Genetic Conditions, Other Carrier Tests

3) By Prenatal Testing: Non-Invasive Prenatal Testing (NIPT), Amniocentesis, Chorionic Villus Sampling (CVS), Ultrasound-Combined Genetic Testing, Other Prenatal Tests

4) By Newborn Screening: Metabolic Disorder Screening, Genetic Disorder Screening, Hearing Loss Screening, Endocrine Disorder Screening, Other Newborn Screening Tests

5) By Other Types: Pharmacogenetic Testing, Forensic Genetic Testing, Ancestry And Genetic Genealogy Testing, Paternity Testing, Other Specialized Genetic Tests

What Industry Trends Are Transforming The Genetic Testing Services Market?

Leading companies operating in the genetic testing services market are concentrating on developing advanced technological solutions, such as cancer screening examinations, to boost accuracy, broaden testing capacities, and elevate overall patient outcomes. Cancer screening tests involve routine, recurrent evaluations performed on individuals without symptoms to identify early indicators of cancer. The objective of these examinations is to pinpoint cancer or precancerous states prior to the onset of symptoms, thereby rendering treatment more efficacious. As an illustration, in May 2025, Guardant Health, a United States-based provider specializing in precision oncology diagnostics, encompassing blood-based liquid biopsies and genetic profiling, introduced the Guardant Hereditary Cancer test. This launch aimed to extend its genetic testing offerings into hereditary cancer risk evaluation, thereby bolstering its screening and prevention framework within oncology care. This Guardant Health examination offers a blood-based 82-gene hereditary cancer panel, which can be combined with Guardant360 from the identical sample, providing prompt outcomes within 2–3 weeks for efficient inherited cancer risk detection.

Who Are The Major Companies Operating In The Genetic Testing Services Market?

Major companies operating in the genetic testing services market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, Agilent Technologies, Hologic Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, NeoGenomics Laboratories Inc, 23andMe Holding Co, Berry Genomics Co. Ltd, Pacific Biosciences of California Inc, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Blueprint Genetics Oy, Igenomix, Veritas Genetics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Genetic Testing Services Market?

North America was the largest region in the genetic testing services market in 2025. The regions covered in the genetic testing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Genetic Testing Services Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15385&type=smp

Browse Through More Reports Similar to the Global Genetic Testing Services Market 2026, By The Business Research Company

Direct To Consumer Dtc Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Genomics Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795